CDERLearn
(mié, 20 nov 2024)
Training and Education for healthcare professionals, academia, and consumers from FDA’s Center for Drug Evaluation and Research
>> Leer más
Public Meeting on the Recommendations for the Over-the-Counter Monograph Drug User Fee Program (OMUFA) Reauthorization - 11/20/2024 - 11/20/2024
(Wed, 20 Nov 2024)
The Food and Drug Administration (FDA or Agency) is announcing a hybrid public meeting to discuss proposed recommendations for the reauthorization of the Over-the-Counter Monograph Drug User Fee
program (OMUFA) for fiscal years (FYs) 2026 through 2030. The virtual public meeting will be held on November 20, 2024, from 9 a.m. to 12:30 p.m. (ET).
>> Leer más